What is the best treatment for patients with human papillomavirus–positive and –negative oropharyngeal cancer?

By  

CANCER, Vol. 120, Iss. 10, 2014-05 ,pp. : 1462-1470

John Wiley & Sons Inc

Access to resources Recommend Favorite

Treatment deintensification and symptom burden in patients with human papillomavirus‐associated head and neck cancer

By  

CANCER, Vol. 121, Iss. 7, 2015-04 ,pp. : 1147-1148

John Wiley & Sons Inc

Access to resources Recommend Favorite

Patient‐reported quality‐of‐life outcomes after de‐escalated chemoradiation for human papillomavirus‐positive oropharyngeal carcinoma: Findings from a phase 2 trial

By  

CANCER, Vol. 124, Iss. 3, 2018-02 ,pp. : 521-529

John Wiley & Sons Inc

Access to resources Recommend Favorite

Staging and treatment of oropharyngeal cancer in the human papillomavirus era

By  

HEAD & NECK: JOURNAL FOR THE SCIENCES & SPECIALTIES OF THE HEAD AND NECK, Vol. 37, Iss. 7, 2015-07 ,pp. : 1002-1013

John Wiley & Sons Inc

Access to resources Recommend Favorite

The rise and fall of prostate brachytherapy: Use of brachytherapy for the treatment of localized prostate cancer in the National Cancer Data Base

By  

CANCER, Vol. 120, Iss. 14, 2014-07 ,pp. : 2114-2121

John Wiley & Sons Inc

Access to resources Recommend Favorite